1. Home
  2. SPOK vs NVCT Comparison

SPOK vs NVCT Comparison

Compare SPOK & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spok Holdings Inc.

SPOK

Spok Holdings Inc.

HOLD

Current Price

$11.14

Market Cap

230.7M

ML Signal

HOLD

Logo Nuvectis Pharma Inc.

NVCT

Nuvectis Pharma Inc.

HOLD

Current Price

$7.93

Market Cap

220.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPOK
NVCT
Founded
2004
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.7M
220.0M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
SPOK
NVCT
Price
$11.14
$7.93
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$14.00
$13.50
AVG Volume (30 Days)
158.7K
52.2K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
11.26%
N/A
EPS Growth
2.74
N/A
EPS
0.75
N/A
Revenue
$139,708,000.00
N/A
Revenue This Year
$1.70
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.80
N/A
Revenue Growth
1.49
N/A
52 Week Low
$10.81
$5.55
52 Week High
$19.31
$11.52

Technical Indicators

Market Signals
Indicator
SPOK
NVCT
Relative Strength Index (RSI) 37.52 44.48
Support Level N/A $7.21
Resistance Level $13.87 $8.46
Average True Range (ATR) 0.26 0.40
MACD 0.05 -0.04
Stochastic Oscillator 52.31 49.67

Price Performance

Historical Comparison
SPOK
NVCT

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Share on Social Networks: